Table 10—

OlgpØDy H.lo Ø erdlpo7de.ellCØo

Firstauthor [ref.no.]AgentsPatients nDose of paclitaxel mg·m−2RRu%StageGrade3–4 neutropeia %
Nair 87Paclitaxe+Cisplati21135, 3 h71E0
44175, 3 h89E2
Grobn 88Paclitaxe+Carboplatin35175, 3 h74L & E27
Gusson 89Paclitaxe+CisplatinEtoposide41130, 3 h90E47
Kelly 9028175, 3 h83E82
Kelly 9190175, 3 h56E35
Mavroudis 9262175, 3 h50L & E44
Birch 93Paclitaxe+Carboplatin+Etoposide84200, 3 h89L & ENR
Fepri 94Docetaxe+Doxoubicine20NR10E17
Morbno 95Docetaxe+Cisplatin307562E60
  • RRu: response rate in untreated patients

  • E: extensivestage

  • L: limited stage

  • NR: not reported